* BIOLASE Inc BIOL.OQ reported a quarterly adjusted loss
of 81
cents per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 68 cents per share.
* Revenue rose 25.3% to $10.17 million from a year ago;
analysts
expected $9.01 million.
* BIOLASE Inc's reported EPS for the quarter was 81 cents.
* The mean earnings estimate of analysts had risen by
about 1.1%
in the last three months.
* In the last 30 days one analyst negatively revised an
earnings
estimate
* BIOLASE Inc shares had fallen by 61.3% this quarter and
lost 64.9% so far this year.
* The company reported a quarterly loss of $4.99 million.
* Wall Street's median 12-month price target for BIOLASE Inc
is
$25.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated May 14 at 12:02 a.m. All
figures in US dollars unless otherwise stated